Gleason pattern 4 or 5 found at a positive surgical margin following robot-assisted radical prostatectomy predicts early biochemical recurrence.
Polymyxin B recommended for routine use in invasive infections; colistin preferred for lower UTI
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
Among Swedish men, overweight or obesity during adolescence tied to higher risk for renal cell carcinoma
Robotic partial nephrectomy offers similar oncologic outcomes to robotic radical nephrectomy, but is associated with better preservation of renal function.
In a study, all men who received testosterone replacement therapy within 1 year of robot-assisted radical prostatectomy had full potency recovery at 24 months.
Testosterone replacement therapy prolonged time to disease progression among men who underwent radical surgery for localized prostate cancer.
Kidney stone recurrence risk increases along with the number of metabolic syndrome components, which include abdominal obesity, hypertension, elevated fasting glucose, low high-density lipoprotein, and elevated triglycerides.
A phase 2 study demonstrated higher rates of pathologic complete response or minimal residual disease.
A population-based study found no effect of low-dose aspirin use within 1 year of diagnosis on prostate cancer death risk.